Oncology is the New Covid | Pfizer CEO, Albert Bourla

In March 2023 Pfizer acquired Seagen, a global biotechnology company that discovers, develops and commercializes cancer medicines. Seagen was forecast to generate $2.2 billion revenue in 2023 yet Pfizer purchased the company for $43 billion. Albert Bourla, Pfizer CEO, is expecting this to be a windfall for his company.

Is Albert Bourla a violent criminal?

SOURCE: https://t.me/hearourvoicesnz/2453